RU2014115999A - Способ мониторинга, диагностики и/или прогнозирования острого повреждения почек на ранней стадии - Google Patents
Способ мониторинга, диагностики и/или прогнозирования острого повреждения почек на ранней стадии Download PDFInfo
- Publication number
- RU2014115999A RU2014115999A RU2014115999/15A RU2014115999A RU2014115999A RU 2014115999 A RU2014115999 A RU 2014115999A RU 2014115999/15 A RU2014115999/15 A RU 2014115999/15A RU 2014115999 A RU2014115999 A RU 2014115999A RU 2014115999 A RU2014115999 A RU 2014115999A
- Authority
- RU
- Russia
- Prior art keywords
- aquaporin
- antibodies
- exosomes
- urine sample
- antibody
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract 36
- 230000006378 damage Effects 0.000 title claims abstract 10
- 238000012544 monitoring process Methods 0.000 title claims abstract 3
- 210000003734 kidney Anatomy 0.000 title claims 8
- 230000001154 acute effect Effects 0.000 title claims 6
- 210000002700 urine Anatomy 0.000 claims abstract 23
- 210000001808 exosome Anatomy 0.000 claims abstract 18
- 102000004888 Aquaporin 1 Human genes 0.000 claims abstract 10
- 108090001004 Aquaporin 1 Proteins 0.000 claims abstract 10
- 108010036221 Aquaporin 2 Proteins 0.000 claims abstract 10
- 108090000991 Aquaporin 3 Proteins 0.000 claims abstract 10
- 102100034414 Aquaporin-2 Human genes 0.000 claims abstract 10
- 201000011040 acute kidney failure Diseases 0.000 claims abstract 7
- 238000005119 centrifugation Methods 0.000 claims abstract 7
- 239000003550 marker Substances 0.000 claims abstract 7
- 208000009304 Acute Kidney Injury Diseases 0.000 claims abstract 6
- 208000033626 Renal failure acute Diseases 0.000 claims abstract 6
- 108091006649 SLC9A3 Proteins 0.000 claims abstract 6
- 102000046061 Sodium-Hydrogen Exchanger 3 Human genes 0.000 claims abstract 6
- 102000056430 Member 1 Solute Carrier Family 12 Human genes 0.000 claims abstract 5
- 108091006621 SLC12A1 Proteins 0.000 claims abstract 5
- 230000003834 intracellular effect Effects 0.000 claims abstract 4
- 102000004169 proteins and genes Human genes 0.000 claims abstract 4
- 108090000623 proteins and genes Proteins 0.000 claims abstract 4
- 210000003850 cellular structure Anatomy 0.000 claims abstract 3
- 238000001471 micro-filtration Methods 0.000 claims abstract 3
- 238000000746 purification Methods 0.000 claims 9
- 102000004363 Aquaporin 3 Human genes 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 6
- 102000012192 Cystatin C Human genes 0.000 claims 5
- 108010061642 Cystatin C Proteins 0.000 claims 5
- 102100034459 Hepatitis A virus cellular receptor 1 Human genes 0.000 claims 5
- 101710185991 Hepatitis A virus cellular receptor 1 homolog Proteins 0.000 claims 5
- -1 IL-1beta Proteins 0.000 claims 5
- 108010051335 Lipocalin-2 Proteins 0.000 claims 5
- 102000013519 Lipocalin-2 Human genes 0.000 claims 5
- 239000003153 chemical reaction reagent Substances 0.000 claims 4
- 102000004190 Enzymes Human genes 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- 239000000872 buffer Substances 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- 239000007850 fluorescent dye Substances 0.000 claims 2
- 230000002285 radioactive effect Effects 0.000 claims 2
- 239000002981 blocking agent Substances 0.000 claims 1
- 238000004140 cleaning Methods 0.000 claims 1
- 230000008105 immune reaction Effects 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 239000011148 porous material Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 238000001228 spectrum Methods 0.000 claims 1
- 239000011550 stock solution Substances 0.000 claims 1
- 239000006228 supernatant Substances 0.000 claims 1
- 238000005199 ultracentrifugation Methods 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 102100037332 Aquaporin-3 Human genes 0.000 abstract 2
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2011/054187 WO2013041913A1 (en) | 2011-09-22 | 2011-09-22 | Method for monitoring, diagnosis and/or prognosis of acute kidney injury in early stage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2014115999A true RU2014115999A (ru) | 2015-10-27 |
Family
ID=47913944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014115999/15A RU2014115999A (ru) | 2011-09-22 | 2011-09-22 | Способ мониторинга, диагностики и/или прогнозирования острого повреждения почек на ранней стадии |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20140329334A1 (enExample) |
| EP (1) | EP2758774A4 (enExample) |
| JP (1) | JP5893742B2 (enExample) |
| KR (1) | KR20140076571A (enExample) |
| CN (1) | CN103917869A (enExample) |
| AU (1) | AU2011377379A1 (enExample) |
| BR (1) | BR112014006741A2 (enExample) |
| CA (1) | CA2849577A1 (enExample) |
| HK (1) | HK1199754A1 (enExample) |
| IL (1) | IL231626A0 (enExample) |
| IN (1) | IN2014DN03194A (enExample) |
| MX (1) | MX2014003422A (enExample) |
| PH (1) | PH12014500650A1 (enExample) |
| RU (1) | RU2014115999A (enExample) |
| WO (1) | WO2013041913A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014182330A1 (en) | 2013-05-06 | 2014-11-13 | Hitachi Chemical Company Ltd | Devices and methods for capturing target molecules |
| FR3014198B1 (fr) * | 2013-12-03 | 2017-03-03 | Biomerieux Sa | Procede d'isolement d'exosomes |
| US20170227541A1 (en) * | 2014-07-17 | 2017-08-10 | The Trustees Of The University Of Pennsylvania | Methods for using exosomes to monitor transplanted organ status |
| US10266895B2 (en) | 2014-11-05 | 2019-04-23 | Hitachi Chemical Company Ltd. | Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease |
| WO2016077484A1 (en) * | 2014-11-11 | 2016-05-19 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| WO2016077537A1 (en) * | 2014-11-12 | 2016-05-19 | Hitachi Chemical Co., Ltd. | Method and device for diagnosing organ injury |
| WO2016140388A1 (ko) * | 2015-03-05 | 2016-09-09 | 경북대학교 산학협력단 | 엑소좀 또는 이의 단백질을 포함하는 장기 독성 진단용 바이오마커 조성물 및 이를 이용한 진단 방법 |
| US20160320390A1 (en) * | 2015-05-01 | 2016-11-03 | Morehouse School Of Medicine | Compositions and methods for capturing exosomes |
| ES2950426T3 (es) * | 2015-08-12 | 2023-10-09 | Univ Columbia | Procedimientos de tratamiento de la depleción de volumen y la lesión renal |
| JP6624704B2 (ja) | 2015-08-31 | 2019-12-25 | 日立化成株式会社 | 尿路上皮疾患の評価のための分子法 |
| JP6531987B2 (ja) * | 2015-10-01 | 2019-06-19 | 国立大学法人名古屋大学 | 腎疾患診断のためのエクソソーム回収法 |
| CN105441578B (zh) * | 2016-01-19 | 2018-08-31 | 中南大学湘雅二医院 | 尿液外泌体microRNA分子标志物的应用及制备的试剂盒 |
| CA3283226A1 (en) | 2016-03-07 | 2025-11-29 | Father Flanagan's Boys' Home Doing Business As Boys Town National Research Hospital | Noninvasive molecular controls |
| CN106053811A (zh) * | 2016-06-05 | 2016-10-26 | 浙江大学 | 一种尿液外泌体elisa的检测方法及其应用 |
| RU2647327C2 (ru) * | 2016-07-05 | 2018-03-15 | Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО КубГМУ Минздрава России) | Способ ранней диагностики хронической болезни почек у пациентов с хронической обструктивной болезнью легких |
| JP2019168223A (ja) * | 2016-08-12 | 2019-10-03 | 公立大学法人和歌山県立医科大学 | エクソソームの膜に存在するタンパク質の検出方法 |
| CN109425742A (zh) * | 2017-08-23 | 2019-03-05 | 迪亚莱博（张家港）生物科技有限公司 | 一种化学发光法快速检测水通道蛋白1的试剂盒 |
| WO2019045049A1 (ja) * | 2017-09-01 | 2019-03-07 | 学校法人帝京大学 | 腎尿細管細胞特異的発現ベクター |
| RU2702023C1 (ru) * | 2018-08-17 | 2019-10-04 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации | Способ диагностики острого повреждения почек после органосохраняющего хирургического лечения локализованного рака почки |
| ES2968898T3 (es) * | 2019-06-06 | 2024-05-14 | Fundacion Instituto De Investig Sanitaria Fundacion Jimenez Diaz | Método in vitro para detectar enfermedad renal |
| EP3904883A1 (en) * | 2020-04-07 | 2021-11-03 | Sciomics GmbH | Prediction and early diagnosis of acute kidney injury |
| RU2765678C1 (ru) * | 2020-12-21 | 2022-02-01 | федеральное государственное бюджетное образовательное учреждение высшего образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации | Способ прогнозирования риска развития острого повреждения почек у больных с острым коронарным синдромом |
| CN113189321B (zh) * | 2021-04-12 | 2024-06-25 | 攸太科技(台州)有限公司 | 一种尿液检测方法 |
| WO2024085722A1 (ko) * | 2022-10-20 | 2024-04-25 | 건국대학교 산학협력단 | 신장 질환의 조기 진단을 위한 바이오마커 조성물 및 이를 이용한 신장 질환의 조기 진단에 필요한 정보를 제공하는 방법 |
| KR20250003155A (ko) * | 2023-06-30 | 2025-01-07 | 연세대학교 산학협력단 | 급성신손상의 회복에 대한 정보 제공 방법 및 이를 이용한 키트 |
| CN116883739B (zh) * | 2023-07-10 | 2026-04-10 | 中国医学科学院生物医学工程研究所 | 一种基于图像识别的尿隐血分类方法和系统 |
| CN119044502A (zh) * | 2024-08-19 | 2024-11-29 | 东南大学 | 尿液单个细胞外囊泡cd35蛋白的检测方法、试剂盒及应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9927320D0 (en) * | 1999-11-18 | 2000-01-12 | Chiron Spa | Exosome separation |
| US20040241176A1 (en) * | 2000-04-27 | 2004-12-02 | Ap Cells. Inc. | Method of producing membrane vesicles |
| WO2004013152A2 (en) * | 2002-08-06 | 2004-02-12 | Duke University | Novel targets for lithium therapy |
| US20050272101A1 (en) * | 2004-06-07 | 2005-12-08 | Prasad Devarajan | Method for the early detection of renal injury |
| US8758991B2 (en) * | 2006-04-26 | 2014-06-24 | University Of Louisville Research Foundation, Inc. | Isolation of membrane vesicles from biological fluids and methods of using same |
| AU2009212543B2 (en) * | 2008-02-01 | 2015-07-09 | The General Hospital Corporation | Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions |
| WO2009116021A1 (en) * | 2008-03-18 | 2009-09-24 | Biotrin Intellectual Properties Limited | Method of assessing kidney function in a human subject |
| WO2010054025A1 (en) * | 2008-11-05 | 2010-05-14 | Abbott Laboratories | Neutrophil gelatinase-associated lipocalin (ngal) protein isoforms enriched from urine and recombinant chinese hamster ovary (cho) cells and related compositions, antibodies, and methods of enrichment, analysis and use |
| EP2350320A4 (en) * | 2008-11-12 | 2012-11-14 | Caris Life Sciences Luxembourg Holdings | METHOD AND SYSTEMS FOR USE OF EXOSOMES FOR THE DETERMINATION OF PHENOTYPES |
| US9476880B2 (en) * | 2008-11-21 | 2016-10-25 | Future Medical Diagnostics Co., Ltd. | Methods, devices and kits for detecting or monitoring acute kidney injury |
| GB0822836D0 (en) * | 2008-12-15 | 2009-01-21 | Oxford Biomedica Ltd | Method |
| EP2433137B1 (en) * | 2009-05-18 | 2015-07-29 | Washington University | Methods of renal cancer detection |
-
2011
- 2011-09-22 KR KR1020147009382A patent/KR20140076571A/ko not_active Withdrawn
- 2011-09-22 JP JP2014531321A patent/JP5893742B2/ja not_active Expired - Fee Related
- 2011-09-22 RU RU2014115999/15A patent/RU2014115999A/ru unknown
- 2011-09-22 BR BR112014006741A patent/BR112014006741A2/pt not_active IP Right Cessation
- 2011-09-22 EP EP20110872834 patent/EP2758774A4/en not_active Withdrawn
- 2011-09-22 MX MX2014003422A patent/MX2014003422A/es not_active Application Discontinuation
- 2011-09-22 PH PH1/2014/500650A patent/PH12014500650A1/en unknown
- 2011-09-22 WO PCT/IB2011/054187 patent/WO2013041913A1/en not_active Ceased
- 2011-09-22 AU AU2011377379A patent/AU2011377379A1/en not_active Abandoned
- 2011-09-22 CN CN201180074742.3A patent/CN103917869A/zh active Pending
- 2011-09-22 US US14/346,679 patent/US20140329334A1/en not_active Abandoned
- 2011-09-22 HK HK15100094.8A patent/HK1199754A1/xx unknown
- 2011-09-22 CA CA2849577A patent/CA2849577A1/en not_active Abandoned
-
2014
- 2014-03-20 IL IL231626A patent/IL231626A0/en unknown
- 2014-04-22 IN IN3194DEN2014 patent/IN2014DN03194A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL231626A0 (en) | 2014-05-28 |
| MX2014003422A (es) | 2014-10-13 |
| WO2013041913A1 (en) | 2013-03-28 |
| AU2011377379A1 (en) | 2014-04-10 |
| HK1199754A1 (en) | 2015-07-17 |
| KR20140076571A (ko) | 2014-06-20 |
| JP2014528076A (ja) | 2014-10-23 |
| CA2849577A1 (en) | 2013-03-28 |
| PH12014500650A1 (en) | 2014-06-02 |
| JP5893742B2 (ja) | 2016-03-23 |
| IN2014DN03194A (enExample) | 2015-05-22 |
| EP2758774A4 (en) | 2015-04-29 |
| BR112014006741A2 (pt) | 2017-03-28 |
| CN103917869A (zh) | 2014-07-09 |
| US20140329334A1 (en) | 2014-11-06 |
| EP2758774A1 (en) | 2014-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014528076A5 (enExample) | ||
| Banasik et al. | Non-HLA antibodies: angiotensin II type 1 receptor (anti-AT1R) and endothelin-1 type A receptor (anti-ETAR) are associated with renal allograft injury and graft loss | |
| BR112014006741A2 (pt) | método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial | |
| WO2010057184A3 (en) | Methods for detection of acute kidney injury in humans | |
| PH12020551371A1 (en) | Assays to detect neurodegeneration | |
| NZ619883A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| WO2010002911A3 (en) | Methods and materials for monitoring myeloma using quantitative mass spetrometry | |
| JP7502430B2 (ja) | 敗血症管理 | |
| RU2017115663A (ru) | Способы и системы для отличия синдрома раздраженного кишечника от воспалительного заболевания кишечника и глютеновой болезни | |
| Munir et al. | Rapid detection of acute kidney injury by urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass surgery | |
| Gandolfini et al. | Rapid biolayer interferometry measurements of urinary CXCL9 to detect cellular infiltrates noninvasively after kidney transplantation | |
| EA201490105A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| JP2012168012A (ja) | 血管内皮障害を検査するための新規な検査方法および検査用キット | |
| RU2013158667A (ru) | Способ диагностики болезни гоше | |
| CN107438767A (zh) | 检测活动性结核病标志物的方法 | |
| WO2010006199A3 (en) | Immunoassays for the detection of anti -non-muscle myosin heavy chain (nmhc)-ii autoantibodies in cardiovascular diseases | |
| ITRM20100121A1 (it) | Marcatori molecolari per infezioni delle vie urinarie. | |
| US10557857B1 (en) | System and method for bone loss assay | |
| JP6083937B2 (ja) | 急性腎障害の検査方法 | |
| Bogo et al. | COVID-19: SARS-CoV-2 Seroprevalence in a Blood Bank in Southern Brazil | |
| Kujat et al. | Monitoring tubular epithelial cell damage in AKI via urine flow cytometry | |
| ES2718689T3 (es) | Método para determinar la concentración de células epiteliales en una muestra de sangre o una muestra de aspirado | |
| JP6865280B2 (ja) | ヘリコバクター・ピロリ胃炎および萎縮性胃炎と関連リスクの改善された検出方法 | |
| Yun et al. | Inflammatory dysfunction in hepatitis B-positive individuals: Quantitative assessment of C-reactive protein (CRP) and Procalcitonin (PCT) levels using immunofluorescence assay | |
| Soleimani et al. | Usefulness of a multiplex immunodot in case of discordant results between automated COVID-19 serological assays |